Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Clinical Lung Cancer|March 10, 2026
Subcutaneous Delivery of Amivantamab in Patients With Advanced Solid Malignancies: The Phase Ib PALOMA StudyAnna Minchom, Byoung Chul Cho, Natasha B Leighl, et al.International Journal of Radiation Oncology, Biology, Physics|December 14, 2005
X-ray volumetric imaging in image-guided radiotherapy: the new standard in on-treatment imagingCatherine A McBain, Ann M Henry, Jonathan Sykes, et al.Hepatology Communications|June 19, 2024
Development and validation of a biomarker index for HCC treatment responseJeff Liang, Po-Yi Li, Joshua Norman, et al.Cancer Causes & Control : CCC|September 4, 2025
Pre-surgery gut microbial diversity and abundance are associated with post-surgery onset of cachexia in colorectal cancer patients: the ColoCare StudyMmadili N Ilozumba, Maria F Gomez, Tengda Lin, et al.Cancer Cell|January 13, 2023
Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapyGaopeng Li, Jae Eun Choi, Ilona Kryczek, et al.Journal of Vascular and Interventional Radiology : JVIR|December 22, 2020
Safety and Efficacy of Segmental Yttrium-90 Radioembolization for Hepatocellular Carcinoma after Transjugular Intrahepatic Portosystemic Shunt CreationAndrew C Gordon, Aakash N Gupta, Ahmed Gabr, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 11, 2024
Consolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLCAmin H Nassar, Ritujith Jayakrishnan, Jamie Feng, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 26, 2024
Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort StudyAmin H Nassar, So Yeon Kim, Jacqueline V Aredo, et al.Nature Communications|August 19, 2025
Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinomaAmin H Nassar, Chul Kim, Tolulope Adeyelu, et al.Nature Communications|February 24, 2021
Continent-wide tree fecundity driven by indirect climate effectsJames S Clark, Robert Andrus, Melaine Aubry-Kientz, et al.Pageof 7